Millennium Management’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $13M | Buy |
1,881,001
+201,988
| +12% | +$1.56M | 0.01% | 1923 |
|
|
2025
Q4 | $14.8M | Sell |
1,679,013
-1,571,823
| -48% | -$8.65M | 0.01% | 1862 |
|
|
2025
Q3 | $16.2M | Buy |
3,250,836
+130,497
| +4% | +$604K | 0.01% | 1904 |
|
|
2025
Q2 | $14.7M | Buy |
3,120,339
+980,748
| +46% | +$4.29M | 0.01% | 1875 |
|
|
2025
Q1 | $9.82M | Buy |
2,139,591
+1,470,898
| +220% | +$6.86M | 0.01% | 2214 |
|
|
2024
Q4 | $3.2M | Buy |
668,693
+269,183
| +67% | +$1.29M | ﹤0.01% | 3245 |
|
|
2024
Q3 | $1.87M | Buy |
399,510
+383,273
| +2,360% | +$2.05M | ﹤0.01% | 3761 |
|
|
2024
Q2 | $91.7K | Sell |
16,237
-416,565
| -96% | -$2.15M | ﹤0.01% | 5326 |
|
|
2024
Q1 | $1.78M | Sell |
432,802
-565,490
| -57% | -$2.26M | ﹤0.01% | 3845 |
|
|
2023
Q4 | $4.21M | Sell |
998,292
-1,017,023
| -50% | -$4.1M | ﹤0.01% | 2927 |
|
|
2023
Q3 | $8.71M | Buy |
2,015,315
+1,435,541
| +248% | +$7.98M | ﹤0.01% | 2179 |
|
|
2023
Q2 | $3.82M | Sell |
579,774
-1,181,954
| -67% | -$7.58M | ﹤0.01% | 2907 |
|
|
2023
Q1 | $12M | Sell |
1,761,728
-22,017
| -1% | -$155K | 0.01% | 1787 |
|
|
2022
Q4 | $13.2M | Buy |
1,783,745
+1,633,788
| +1,090% | +$15.9M | 0.01% | 1842 |
|
|
2022
Q3 | $1.48M | Sell |
149,957
-1,040,453
| -87% | -$11M | ﹤0.01% | 4010 |
|
|
2022
Q2 | $13M | Buy |
1,190,410
+356,418
| +43% | +$3.69M | 0.01% | 1734 |
|
|
2022
Q1 | $9.43M | Buy |
833,992
+394,318
| +90% | +$5.18M | 0.01% | 2223 |
|
|
2021
Q4 | $6.9M | Sell |
439,674
-167,070
| -28% | -$2.91M | ﹤0.01% | 2564 |
|
|
2021
Q3 | $10.4M | Buy |
606,744
+351,137
| +137% | +$6.15M | 0.01% | 2004 |
|
|
2021
Q2 | $5.5M | Sell |
255,607
-461,108
| -64% | -$8.25M | ﹤0.01% | 2634 |
|
|
2021
Q1 | $10.8M | Buy |
716,715
+73,005
| +11% | +$1.18M | 0.01% | 1692 |
|
|
2020
Q4 | $8.46M | Buy |
643,710
+476,053
| +284% | +$5.73M | 0.01% | 1921 |
|
|
2020
Q3 | $1.62K | Buy |
+167,657
| New | +$1.79M | ﹤0.01% | 2760 |
|
|
2020
Q2 | – | Sell |
-280,178
| Closed | -$2.9M | – | 4628 |
|
|
2020
Q1 | $2.9M | Buy |
280,178
+266,565
| +1,958% | +$3.31M | 0.01% | 1752 |
|
|
2019
Q4 | $223K | Sell |
13,613
-448,362
| -97% | -$6.78M | ﹤0.01% | 3822 |
|
|
2019
Q3 | $6.13M | Sell |
461,975
-60,350
| -12% | -$841K | 0.01% | 1642 |
|
|
2019
Q2 | $7.36M | Sell |
522,325
-135,697
| -21% | -$2.16M | 0.01% | 1483 |
|
|
2019
Q1 | $12.1M | Buy |
658,022
+72,158
| +12% | +$1.64M | 0.02% | 1112 |
|
|
2018
Q4 | $15.3M | Buy |
585,864
+293,273
| +100% | +$6.9M | 0.02% | 856 |
|
|
2018
Q3 | $6.71M | Sell |
292,591
-97,811
| -25% | -$2M | 0.01% | 1594 |
|
|
2018
Q2 | $7.44M | Sell |
390,402
-605,873
| -61% | -$10.1M | 0.01% | 1518 |
|
|
2018
Q1 | $16.8M | Sell |
996,275
-131,290
| -12% | -$2.2M | 0.02% | 988 |
|
|
2017
Q4 | $17.1M | Sell |
1,127,565
-313,196
| -22% | -$4.65M | 0.02% | 998 |
|
|
2017
Q3 | $25.8M | Buy |
1,440,761
+1,006,282
| +232% | +$16.8M | 0.04% | 650 |
|
|
2017
Q2 | $7.08M | Sell |
434,479
-134,864
| -24% | -$1.94M | 0.01% | 1269 |
|
|
2017
Q1 | $7.97M | Sell |
569,343
-451,828
| -44% | -$6.44M | 0.01% | 1159 |
|
|
2016
Q4 | $16.3M | Sell |
1,021,171
-660,510
| -39% | -$10.6M | 0.03% | 677 |
|
|
2016
Q3 | $28M | Buy |
1,681,681
+1,244,770
| +285% | +$16.8M | 0.05% | 443 |
|
|
2016
Q2 | $4.89M | Sell |
436,911
-1,731,825
| -80% | -$16.8M | 0.01% | 1273 |
|
|
2016
Q1 | $18.1M | Buy |
2,168,736
+632,966
| +41% | +$5.2M | 0.05% | 529 |
|
|
2015
Q4 | $14.3M | Sell |
1,535,770
-259,698
| -14% | -$2.59M | 0.03% | 720 |
|
|
2015
Q3 | $20.3M | Buy |
1,795,468
+711,709
| +66% | +$8.71M | 0.04% | 560 |
|
|
2015
Q2 | $13.8M | Sell |
1,083,759
-515,403
| -32% | -$5.56M | 0.03% | 800 |
|
|
2015
Q1 | $14.9M | Buy |
1,599,162
+786,392
| +97% | +$8.89M | 0.03% | 830 |
|
|
2014
Q4 | $11.6M | Buy |
812,770
+193,191
| +31% | +$2.29M | 0.02% | 901 |
|
|
2014
Q3 | $6.43M | Buy |
619,579
+359,372
| +138% | +$4.71M | 0.02% | 1132 |
|
|
2014
Q2 | $4.21M | Buy |
260,207
+60,207
| +30% | +$802K | 0.01% | 1311 |
|
|
2014
Q1 | $3.25M | Sell |
200,000
-678,530
| -77% | -$9.65M | 0.01% | 1463 |
|
|
2013
Q4 | $10.9M | Sell |
878,530
-451,090
| -34% | -$4.53M | 0.03% | 648 |
|
|
2013
Q3 | $14.6M | Buy |
1,329,620
+780,722
| +142% | +$8.34M | 0.05% | 512 |
|
|
2013
Q2 | $4.43M | Buy |
+548,898
| New | +$3.7M | 0.01% | 1104 |
|
Other funds holding VNDA
ACM
VCM
Millennium Management's VNDA Position: Q1 2026 in Review
Millennium Management increased its Vanda Pharmaceuticals (VNDA) stake by 12% in Q1 2026, buying an estimated $1.56M and bringing the position to 1,881,001 shares worth $13M. The position accounts for 0.01% of the portfolio, ranked #1923.
Millennium Management first reported a position in VNDA in Q2 2013 and has held it in 51 quarters since. The position peaked at $28M in Q3 2016. 170 funds tracked by Wall St. Rank hold VNDA as of Q1 2026.
- Millennium Management held 1,881,001 shares of Vanda Pharmaceuticals worth $13M as of Q1 2026.
- Millennium Management bought 201,988 Vanda Pharmaceuticals shares in Q1 2026, an estimated $1.56M.
- Vanda Pharmaceuticals made up 0.01% of Millennium Management's portfolio in Q1 2026, its #1923 holding.
- Millennium Management first reported a position in Vanda Pharmaceuticals in Q2 2013 and has held it in 51 quarters since.
- Millennium Management's Vanda Pharmaceuticals position peaked at $28M in Q3 2016.
- 170 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q1 2026.
Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.